Binding affinity using [125I]ABA against human Adenosine A1 receptor
|
Homo sapiens
|
99.0
nM
|
|
Binding affinity for rat Adenosine A1 receptor in CHO cells using [3H]N6-(R)-phenylisopropyladenosine
|
Rattus norvegicus
|
820.0
nM
|
|
Binding affinity for adenosine A1 receptor as inhibition of 3[H]-R-PIA binding in rat brain
|
Rattus norvegicus
|
54.0
nM
|
|
Binding affinity for adenosine A1 receptor as displacement of [3H]R-PIA from rat brain membranes at 10e-4 M
|
Rattus norvegicus
|
820.0
nM
|
|
Tested for the binding affinity of A1 receptor by displacing the [3H]-PIA in rat brain membranes
|
None
|
820.0
nM
|
|
Binding affinity using [125I]ABA against human Adenosine A3 receptor
|
Homo sapiens
|
14.0
nM
|
|
Binding affinity for rat adenosine A2A receptor of CHO cells using [3H]CGS-21680
|
Rattus norvegicus
|
470.0
nM
|
|
Binding affinity for adenosine A2A receptor as displacement of [3H]-CGS- 21680 from rat striatal membranes at 10e-4 M
|
Rattus norvegicus
|
470.0
nM
|
|
Binding affinity of adenosine derivative for endogenous rat Adenosine A3 receptor expressed on CHO cell
|
None
|
0.9
nM
|
|
Binding affinity for rat Adenosine A3 receptor in CHO cells [125I]-iodo-AB-MECA
|
Rattus norvegicus
|
0.33
nM
|
|
Binding affinity for rat Adenosine A3 receptor
|
Rattus norvegicus
|
0.33
nM
|
|
Tested for the binding affinity of A3 receptor by displacing N6-[[125I]-4-amino-3-iodobenzyl]-adenosine-5''-N-methyluronamide from membranes of CHO cells transfected with rat A3-cDNA
|
None
|
0.33
nM
|
|
Binding affinity towards human Adenosine A3 receptor wild type
|
None
|
2.3
nM
|
|
Binding affinity for adenosine A2a receptor as inhibition of 3[H]-CGS 21680 binding in rat striatum
|
Rattus norvegicus
|
56.0
nM
|
|
Tested for the binding affinity of A2a receptor by displacing the [3H]-CGS- 21680 in rat striatal membranes
|
None
|
470.0
nM
|
|
Effect on forskolin-stimulated cyclic AMP production in intact chinese hamster ovary (CHO) cell expressing the human Adenosine A3 receptor
|
None
|
2.8
nM
|
|
Affinity for human Adenosine A3 receptor expressed in CHO cell
|
None
|
1.4
nM
|
|
Binding affinity at Mutant (H272E) human adenosine A3 receptor expressed in COS-7 cells
|
None
|
20.1
nM
|
|
Binding affinity at wild-type Adenosine A3 receptor expressed in COS-7 cells
|
None
|
4.3
nM
|
|
Binding affinity for human Adenosine A3 receptor in CHO cells using [125I]-iodo-AB-MECA
|
Homo sapiens
|
1.0
nM
|
|
Binding affinity for adenosine A3 receptor as inhibition of [125I]AB-MECA binding to human receptor expressed in HEK 293 cells
|
Homo sapiens
|
1.1
nM
|
|
Binding affinity towards Adenosine A3 receptor (H95A mutant receptor)
|
None
|
60.0
nM
|
|
Binding affinity towards Adenosine A3 receptor (W243 mutant) receptor
|
Homo sapiens
|
2.9
nM
|
|
Displacement of [125I]AB-MECA from adenosine A3 receptor from HEK293 cell membranes
|
Homo sapiens
|
0.33
nM
|
|
Binding affinity for CHO cell membrane expressing human A3AR with GTPgammaS using [3H]8-ethyl-4-methyl-2-phenyl-(8R)-4,5,7,8-tetrahydro-1H-imidazo[2,1-i]-purin-5-one
|
Homo sapiens
|
6.3
nM
|
|
Binding affinity for CHO cell membrane expressing human Adenosine A3 receptor using [3H]8-ethyl-4-methyl-2-phenyl-(8R)-4,5,7,8-tetrahydro-1H-imidazo[2,1-i]-purin-5-one
|
Homo sapiens
|
1.5
nM
|
|
Displacement of [125I]-AB MECA from recombinant human adenosine A3 receptor expressed in HEK cells
|
Homo sapiens
|
1.4
nM
|
|
Inhibition of [3H]R-PIA binding to human Adenosine A1 receptor expressed in CHO cells
|
Homo sapiens
|
220.0
nM
|
|
Inhibition of [125I]AB-MECA binding to rat Adenosine A3 receptor expressed in CHO cells
|
Rattus norvegicus
|
0.33
nM
|
|
Inhibition of [125I]-AB-MECA binding to human Adenosine A3 receptor expressed in CHO cells
|
Homo sapiens
|
1.4
nM
|
|
Displacement of [3H]CHA binding to Adenosine A1 receptor expressed in CHO cells
|
Homo sapiens
|
823.0
nM
|
|
Displacement of [3H]CGS-21680 binding to Adenosine A2 receptor expressed in CHO cells
|
Homo sapiens
|
448.0
nM
|
|
Displacement of [125I]AB-MECA binding to Adenosine A3 receptor expressed in CHO cells
|
Homo sapiens
|
0.33
nM
|
|
Binding affinity towards recombinant human Adenosine A1 receptor was determined using [3H]R-PIA (2.0 nM) as radioligand
|
Homo sapiens
|
222.0
nM
|
|
Displacement of [3H]DPCPX binding to adenosine A1 receptors of bovine cortical membranes
|
Bos taurus
|
890.0
nM
|
|
Displacement of [3H]CGS-21680 binding to adenosine A2A receptors of bovine striatal membranes
|
Bos taurus
|
401.0
nM
|
|
Displacement of [125I]AB-MECA from adenosine A3 receptors in bovine cortical membranes
|
Bos taurus
|
0.22
nM
|
|
Binding affinity towards human Adenosine A3 receptor stably transfected in CHO cells was determined using [125I]I-AB-MECA (1.0 nM) as radioligand
|
Homo sapiens
|
1.4
nM
|
|
Inhibition of (10 uM) forskolin-mediated cAMP production in CHO cells expressing human Adenosine A3 receptor
|
Homo sapiens
|
2.2
nM
|
|
Displacement of [125I]ABA from human adenosine A1 receptor expressed in HEK cells
|
Homo sapiens
|
5.26
nM
|
|
Displacement of [125I]ZM-241385 from human adenosine A2A receptor in HEK cells at 100 uM
|
Homo sapiens
|
50.0
%
|
|
Displacement of [125I]ABOPX from human adenosine A2B receptor in HEK cells at 100 uM
|
Homo sapiens
|
50.0
%
|
|
Displacement of [125I]ABA from human adenosine A3 receptor expressed in HEK cells
|
Homo sapiens
|
0.637
nM
|
|
Displacement of [3H]CCPA from human adenosine A1 receptor in CHO cells
|
Homo sapiens
|
222.0
nM
|
|
Displacement of [125I]AB-MECA from human adenosine A3 receptor expressed in CHO cells
|
Homo sapiens
|
1.4
nM
|
|
Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO cells
|
Homo sapiens
|
890.0
nM
|
|
Displacement of [3H]NECA from human adenosine A2A receptor expressed in CHO cells
|
Homo sapiens
|
401.0
nM
|
|
Displacement of [3H]AB-MECA from human adenosine A3 receptor expressed in CHO cells
|
Homo sapiens
|
0.22
nM
|
|
Displacement of [3H]CCPA from human adenosine A1 receptor expressed in CHO cells
|
Homo sapiens
|
222.0
nM
|
|
Displacement of [3H]ABMECA from human adenosine A3 receptor expressed in CHO cells
|
Homo sapiens
|
1.4
nM
|
|
Agonist activity at human adenosine A3 receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP
|
Homo sapiens
|
1.2
nM
|
|
Displacement of [3H]DPDPX from human adenosine A1 receptor expressed in CHO cells
|
Homo sapiens
|
890.0
nM
|
|
Displacement of [3H]NECA from human adenosine A2A receptor expressed in CHO cells
|
Homo sapiens
|
401.0
nM
|
|
Displacement of [125I]AB-MECA from human adenosine A3 receptor expressed in CHO cells
|
Homo sapiens
|
0.22
nM
|
|
Displacement of [125I]N6-(4-amino-3-iodobenzyl)adenosine-5'-N-methyl-uronamide from mouse recombinant adenosine A1 receptor expressed in HEK293 cells
|
Mus musculus
|
35.0
nM
|
|
Displacement of [125I]N6-(-amino-3-iodobenzyl)adenosine-5'-N-methyl-uronamide from mouse recombinant adenosine A3 receptor expressed in HEK293 cells
|
Mus musculus
|
0.18
nM
|
|
Displacement of radioligand from human adenosine A1 receptor expressed in CHO cells
|
Homo sapiens
|
220.0
nM
|
|
Displacement of radioligand from human adenosine A3 receptor expressed in CHO cells
|
Homo sapiens
|
1.4
nM
|
|
Displacement of radioligand from rat adenosine A1 receptor
|
Rattus norvegicus
|
820.0
nM
|
|
Displacement of radioligand from rat adenosine A2A receptor
|
Rattus norvegicus
|
470.0
nM
|
|
Displacement of radioligand from rat A3 adenosine receptor
|
Rattus norvegicus
|
0.33
nM
|
|
Displacement of [125I]I-AB-MEAC from human adenosine A3 receptor expressed in CHO cells
|
Homo sapiens
|
0.3802
nM
|
|
Displacement of [3H]CCPA form human adenosine A1 receptor expressed in CHO cells
|
Homo sapiens
|
222.0
nM
|
|
Displacement of [3H]CGS21680 form human adenosine A3 receptor expressed in CHO cells
|
Homo sapiens
|
1.4
nM
|
|
Displacement of [3H]CCPA from human adenosine A1 receptor expressed in CHO cells
|
Homo sapiens
|
222.0
nM
|
|
Displacement of [125I]I-AB-MECA from human adenosine A3 receptor expressed in CHO cells
|
Homo sapiens
|
1.4
nM
|
|
Displacement of [125I]I-AB-MECA from rat adenosine A3 receptor expressed in CHO cells
|
Rattus norvegicus
|
0.33
nM
|
|
Displacement of [3H]NECA from human recombinant adenosine A1 receptor expressed in CHO cells by liquid scintillation counting
|
Homo sapiens
|
220.0
nM
|
|
Displacement of [3H]I-AB-MECA from human recombinant adenosine A3 receptor expressed in CHO cells by liquid scintillation counting
|
Homo sapiens
|
1.4
nM
|
|
Binding affinity to human adenosine A3 receptor
|
Homo sapiens
|
1.0
nM
|
|
Displacement of [3H]R-PIA from human adenosine A1 receptor expressed in CHO cells
|
Homo sapiens
|
222.0
nM
|
|
Displacement of [125I]AB-MECA from human adenosine A3 receptor expressed in CHO cells
|
Homo sapiens
|
1.4
nM
|
|
Displacement of [3H]DPCPX from human A1 adenosine receptor expressed in CHO cell membrane
|
Homo sapiens
|
890.0
nM
|
|
Displacement of [3H]NECA from human A2A adenosine receptor expressed in CHO cell membrane
|
Homo sapiens
|
401.0
nM
|
|
Displacement of [125I]AB-MECA from human A3 adenosine receptor expressed in CHO cell membrane
|
Homo sapiens
|
0.22
nM
|
|
Displacement of [125I]I-AB-MECA from human recombinant adenosine A3 receptor expressed in CHO cells after 60 mins by gamma counter
|
Homo sapiens
|
2.2
nM
|
|
Displacement of [125I]I-AB-MECA from human rat adenosine A3 receptor expressed in CHO cells after 60 mins by gamma counter
|
Rattus norvegicus
|
0.33
nM
|
|
Displacement of [3H]CCPA from rat adenosine A1 receptor expressed in CHO cells after 60 mins by gamma counter
|
Rattus norvegicus
|
820.0
nM
|
|
Displacement of [3H]CGS21680 from rat adenosine A2A receptor expressed in CHO cells after 60 mins by gamma counter
|
Rattus norvegicus
|
470.0
nM
|
|
Agonist activity at mouse adenosine A3 receptor expressed in HEK293 cell membranes assessed as inhibition of forskolin-stimulated cAMP production preincubated for 30 mins prior to forskolin-treatment measured after 15 mins by ELISA
|
Mus musculus
|
0.15
nM
|
|
Displacement of [125I]I-AB-MECA from human adenosine A3 receptor expressed in CHO cells after 90 mins by gamma counting analysis
|
Homo sapiens
|
1.4
nM
|
|
Competitive binding affinity to human adenosine A3 receptor expressed in CHO cells after 90 mins by flow cytometric analysis in presence of MRS5449
|
Homo sapiens
|
27.7
nM
|
|
Displacement of [125I]AB-MECA from human adenosine A3 receptor expressed in CHO cell membrane after 90 mins
|
Homo sapiens
|
0.22
nM
|
|
Displacement of [3H]NECA from human adenosine A2A receptor expressed in CHO cell membrane after 90 mins
|
Homo sapiens
|
401.0
nM
|
|
Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO cell membrane after 180 mins
|
Homo sapiens
|
890.0
nM
|
|
Binding affinity to A3AR (unknown origin)
|
Homo sapiens
|
1.0
nM
|
|
Agonist activity at human recombinant A3AR expressed in CHO cells assessed as inhibition of forskolin-induced stimulation of cAMP production
|
Homo sapiens
|
1.21
nM
|
|
Binding affinity to Adenosine receptor A3 (unknown origin)
|
Homo sapiens
|
1.4
nM
|
|
Agonist activity at mouse adenosine A3 receptor expressed in HEK293 cell membranes assessed as inhibition of forskolin-stimulated cAMP accumulation preincubated for 30 mins followed by forsolkin addition measured after 15 mins by immunoassay
|
Mus musculus
|
0.46
nM
|
|
Displacement of [3H]WAY100635 from human 5-HT1AR expressed in CHO cell membranes at 10 uM incubated for 90 mins under dark condition by microbeta scintillation counting method relative to control
|
Homo sapiens
|
50.0
%
|
|
Displacement of [3H]5-CT from human 5-HT1BR expressed in HEK cell membranes at 10 uM incubated for 90 mins under dark condition by microbeta scintillation counting method relative to control
|
Homo sapiens
|
50.0
%
|
|
Displacement of [3H]5-CT from human 5-HT1D receptor expressed in HEK-T cell membranes at 10 uM incubated for 90 mins under dark condition by microbeta scintillation counting method relative to control
|
Homo sapiens
|
50.0
%
|
|
Displacement of [3H]5-HT from human 5-HT1E receptor expressed in HEK cell membranes at 10 uM incubated for 90 mins under dark condition by microbeta scintillation counting method relative to control
|
Homo sapiens
|
50.0
%
|
|
Displacement of [3H]GR113808 from human 5-HT4 receptor at 10 uM incubated for 90 mins under dark condition by microbeta scintillation counting method relative to control
|
Homo sapiens
|
50.0
%
|
|
Displacement of [3H]LSD from human 5-HT6 receptor expressed in HEK cell membranes at 10 uM incubated for 90 mins under dark condition by microbeta scintillation counting method relative to control
|
Homo sapiens
|
50.0
%
|
|
Displacement of [3H]LSD from human 5-HT7A receptor expressed in HEK cell membranes at 10 uM incubated for 90 mins under dark condition by microbeta scintillation counting method relative to control
|
Homo sapiens
|
50.0
%
|
|
Displacement of [3H]GR65630 from human 5-HT3 receptor expressed in HEK-T cell membranes at 10 uM incubated for 90 mins under dark condition by microbeta scintillation counting method relative to control
|
Homo sapiens
|
50.0
%
|
|
Displacement of [3H]LSD from human 5-HT5A receptor expressed in Flp-In-CHO cell membranes incubated for 90 mins under dark condition by microbeta scintillation counting method relative to control
|
Homo sapiens
|
50.0
%
|
|
Displacement of [3H]ketanserin from human 5-HT2A receptor expressed in HEK-T cell membranes at 10 uM incubated for 90 mins under dark condition by microbeta scintillation counting method relative to control
|
Homo sapiens
|
30.0
%
|
|
Displacement of [3H]lysergic from human 5-HT2BR expressed in HEK cell membranes at 10 uM incubated for 90 mins under dark condition by microbeta scintillation counting method relative to control
|
Homo sapiens
|
50.0
%
|
|
Displacement of [3H]mesulergine from human 5-HT2CR expressed in Flp-In HEK cell membranes at 10 uM incubated for 90 mins under dark condition by microbeta scintillation counting method relative to control
|
Homo sapiens
|
50.0
%
|
|
Displacement of [3H]N6-phenylisopropyladenosine from recombinant human A1AR expressed in CHO cell membranes after 60 mins by liquid scintillation counting method
|
Homo sapiens
|
220.0
nM
|
|
Displacement of [125I]I-AB-MECA from human adenosine A3 receptor expressed in CHO cells after 60 mins by gamma counting analysis
|
Homo sapiens
|
1.4
nM
|
|
Displacement of [125I]I-AB-MECA from human A3 adenosine receptor expressed in CHO cell membranes after 60 mins by gamma counting method
|
Homo sapiens
|
1.4
nM
|
|
Displacement of [3H]CCPA from human A1 receptor expressed in CHO cell membranes after 60 mins by gamma counting method
|
Homo sapiens
|
222.0
nM
|
|
Displacement of Fluormone-Pan-PPAR Green from human GST-tagged PPARgamma LBD at 4 uM by TR-FRET assay relative to control
|
Homo sapiens
|
59.0
%
|
|
Displacement of Fluormone-Pan-PPAR Green from human GST-tagged PPARdelta LBD at 4 uM by TR-FRET assay relative to control
|
Homo sapiens
|
75.0
%
|
|
Displacement of Fluormone-Pan-PPAR Green from human GST-tagged PPARalpha LBD at 20 uM by TR-FRET assay relative to control
|
Homo sapiens
|
46.5
%
|
|
Displacement of Fluormone-Pan-PPAR Green from human GST-tagged PPARgamma LBD by TR-FRET assay
|
Homo sapiens
|
2.18
nM
|
|
Displacement of Fluormone-Pan-PPAR Green from human GST-tagged PPARdelta LBD by TR-FRET assay
|
Homo sapiens
|
0.43
nM
|
|
Displacement of [3H]NECA from recombinant human adenosine A3 receptor expressed in CHO cell membranes measured after 180 mins
|
Homo sapiens
|
0.2
nM
|
|
Displacement of [3H]CCPA from human adenosine A1 receptor expressed in CHO cell membranes after 3 hrs by micro beta scintillation counting method
|
Homo sapiens
|
220.0
nM
|
|
Displacement of [3H]HEMADO from human adenosine A3 receptor expressed in CHO cell membranes after 3 hrs by micro beta scintillation counting method
|
Homo sapiens
|
1.4
nM
|
|
Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells at 10 uM after 48 hours by high content imaging
|
Homo sapiens
|
-5.44
%
|
|
Partial agonist activity at recombinant human A3AR expressed in HEK293 cells assessed as inhibition of forskolin-stimulated cAMP accumulation measured after 30 mins in presence of A2BAR blocker PSB-603 by Glo-sensor assay
|
Homo sapiens
|
4.1
nM
|
|
SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM by FRET kind of response from peptide substrate
|
Severe acute respiratory syndrome coronavirus 2
|
11.8
%
|
|
SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM by FRET kind of response from peptide substrate
|
Severe acute respiratory syndrome coronavirus 2
|
22.49
%
|
|
Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging
|
Chlorocebus sabaeus
|
0.03
%
|
|
Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging
|
Chlorocebus sabaeus
|
-0.27
%
|
|
Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging
|
Chlorocebus sabaeus
|
-0.27
%
|
|
Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging
|
Chlorocebus sabaeus
|
0.03
%
|
|
Competitive binding affinity to GST-tagged human PPARdelta LBD incubated for 1 to 6 hrs by TR-FRET assay
|
Homo sapiens
|
191.0
nM
|
|
Binding affinity to human A3AR assessed as inhibitor constant
|
Homo sapiens
|
1.4
nM
|
|
Agonist activity at human A3 adenosine receptor expressed in CHO cells assessed as inhibition of forskolin stimulated cAMP formation incubated for 45 mins followed by forskolin stimulation and measured after 15 mins by liquid scintillation spectrometry analysis
|
Homo sapiens
|
1.21
nM
|
|